ライフサイエンスコーパス: remains high

1 HIV incidence among young women in sub-Saharan Africa remains high and their inclusion in vaccine and cure efforts

2 mated overall seroprevalence of hepatitis B surface antigen remains high at 6.1% (95% uncertainty interval 4.6-8.5).

3 ress syndrome (ARDS), the morbidity and mortality from ARDS remains high.

4 d by treatment, the net chance of a longer survival benefit remains high and tends to the cure rate.

5 liquid biofuels and chemicals from lignocellulosic biomass remains high on the sustainability agenda, but is challenged

6 hough incidence is stabilising in western countries, burden remains high as prevalence surpasses 0.3%.

7 y in low-income settings, where pneumococcal disease burden remains high.

8 in a reduction in the incidence in adults where the burden remains high.

9 ous work has shown that the level of nonphosphorylated BvgA remains high in vivo under conditions in which BvgA is phosph

10 of cardiovascular disease in the African American community remains high and is a primary cause of disparities in life ex

11 Mortality in cardiogenic shock (CS) remains high.

12 dial infarction (AMI) complicated by cardiogenic shock (CS) remains high.

13 Despite setbacks, interest in Jatropha cultivation remains high.

14 The incidence of infant GBS disease remains high in some regions, particularly Africa.

15 Case fatality from these diseases remains high and treatment is limited by scarcity of resource

16 ards extinction, in general the overall ecosystem diversity remains high.

17 if the rates of transplant recipients presenting to the ED remains high.

18 se on a global scale, and the potential for CHIKV epidemics remains high.

19 ignificantly during the past three decades, the current ESR remains high in China.

20 The risk of ESRD remains high among HIV-infected individuals in care but is de

21 chronically stimulated Ag-specific T cells, PD-1 expression remains high, leading to an impaired response to stimuli.

22 In the DCCT/EDIC cohort, patient-reported visual function remains high in both treatment groups, comparable to previous

23 This said, hope remains high that any of a number of emerging technologies (e

24 ggesting that systematic treatment in PWID, where incidence remains high, would be beneficial.

25 however, even in the HAART era, incidence of HBV infection remains high among MSM.

26 e incidence of human immunodeficiency virus (HIV) infection remains high among women in sub-Saharan Africa.

27 ertion of effort can be elevated, even when intelligibility remains high.

28 ing chemistries for concurrent multisite-directed labeling, remains high.

29 pies, the burden of recurrent ischemic events and mortality remains high, and future research is ongoing to prevent and i

30 ades, yet gaps in the quality of care persist and mortality remains high.

31 respiratory distress syndrome (ARDS) exists, and mortality remains high.

32 heart failure and reduced ejection fraction, but mortality remains high.

33 India, as in many developing countries, childhood mortality remains high and the quality of health care available is low.

34 y improved in the past decade in Malawi; however, mortality remains high in specific subgroups.

35 However, mortality remains high, at 8% in children and 15% in adults in clinical

36 lethal syndrome: although outcomes have improved, mortality remains high.

37 Despite recent advancements, incidence of PGD remains high.

38 Mortality from pneumococcal pneumonia remains high despite antibiotic therapy, highlighting the pat

39 Obesity prevalence remains high and thus it is important to continue surveillanc

40 Given that smoking prevalence remains high worldwide, these findings are relevant to the co

41 gical repair of a ruptured abdominal aortic aneurysm (rAAA) remains high.

42 For head and neck tumor survivors, this excess risk remains high across all ages.

43 Nonetheless, residual risk remains high, and statin intolerance is frequently encountere

44 risk of traveler's diarrhea in many destinations, the risk remains high in others.

45 ast, prehospital mortality from sudden cardiac arrest (SCA) remains high and difficult to reduce.

46 Hepatitis C virus (HCV) seroprevalence remains high in people who inject drug (PWID) populations, of

47 eatment for aortic stenosis, long-term mortality after TAVR remains high and challenging to predict.

48 The risk of recurrence following radiation therapy remains high for a significant number of prostate cancer pati

49 of uncertainty in selecting the most appropriate treatment remains high and their adoption remains inconsistent across t

50 China, the prevalence of pulmonary tuberculosis in Xinjiang remains high.